Quality of life, neurocognitive functioning, psychological issues, sexuality and comorbidity more than 2 years after commencing immune checkpoint inhibitor treatment
Background Increasing numbers of patients diagnosed with advanced cancer survive long-term after treatment with immune checkpoint inhibitors (ICIs). To design adequate interventions for these survivors, knowledge regarding quality of life (QOL) and its association with long-term and late effects of...
Saved in:
| Main Authors: | Melanie M van der Klauw, T Jeroen N Hiltermann, Mathilde Jalving, Emoke Racz, Sjoukje Oosting, Anna K L Reyners, Wellington Candido, Annemarie Cecile Eggen, Ingeborg Bosma, Reinate D Horinga, Kelly C van Heuvelen, Janine Nuver |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-03-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/3/e011168.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Commencement
by: Gabriel Pulido
Published: (2025-05-01) -
Fin ou commencement ?
by: Françoise Besson
Published: (2020-03-01) -
L’archange des commencements
by: Tereza Sinigalia
Published: (2022-05-01) -
Political Context and State-Level Health Behavior Disparities
by: Jane S. VanHeuvelen, et al.
Published: (2024-10-01) -
Au commencement était le voyage…
by: Melissa Melodias
Published: (2024-10-01)